Literature DB >> 14754961

Ipsilateral hemangioma and aortic arch anomalies in posterior fossa malformations, hemangiomas, arterial anomalies, coarctation of the aorta, and cardiac defects and eye abnormalities (PHACE) anomaly: report and review.

Gabriele Bronzetti1, Alessandro Giardini, Annalisa Patrizi, Daniela Prandstraller, Andrea Donti, Roberto Formigari, Marco Bonvicini, Fernando Maria Picchio.   

Abstract

Posterior fossa malformations, hemangiomas, arterial anomalies, coarctation of the aorta, and cardiac defects and eye abnormalities (PHACE) is a rare congenital anomaly with a broad spectrum of clinical manifestations with a striking female predominance. We describe an infant with PHACE anomaly and aortic coarctation who underwent cardiac catheterization to clearly define the complex anatomy of the aortic lesion before surgical repair. Review of the literature documents a highly significant association between ipsilateral hemangiomas and cerebrovascular and aortic arch anomalies. We conclude that cardiac catheterization is required to define the complex anatomy of aortic lesions and should be performed in all patients with PHACE and evident aortic involvement to plan appropriate and safe surgical repair.

Entities:  

Mesh:

Year:  2004        PMID: 14754961     DOI: 10.1542/peds.113.2.412

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome.

Authors:  C P Hess; H J Fullerton; D W Metry; B A Drolet; D H Siegel; K I Auguste; N Gupta; A N Haggstrom; C F Dowd; I J Frieden; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2010-08-12       Impact factor: 3.825

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

3.  A report of two cases with dolichosegmental intracranial arteries as a new feature of PHACES syndrome.

Authors:  Carlos E Baccin; Timo Krings; Hortensia Alvarez; Augustin Ozanne; Pierre L Lasjaunias
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

4.  PHACES syndrome with small, late-onset hemangiomas.

Authors:  Birgin Torer; Hande Gulcan; Hasan Kilicdag; Murat Derbent
Journal:  Eur J Pediatr       Date:  2007-01-12       Impact factor: 3.183

5.  PHACE Syndrome: Persistent Fetal Vascular Anomalies. A Case Report.

Authors:  V Prochazka; T Hrbac; J Chmelova; D Skoloudik; M Prochazka
Journal:  Interv Neuroradiol       Date:  2006-02-10       Impact factor: 1.610

6.  Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry).

Authors:  Michelle L Bayer; Peter C Frommelt; Francine Blei; Johannes M P J Breur; Maria R Cordisco; Ilona J Frieden; Deborah S Goddard; Kristen E Holland; Alfons L Krol; Mohit Maheshwari; Denise W Metry; Kimberly D Morel; Paula E North; Elena Pope; Joseph T Shieh; James F Southern; Orli Wargon; Dawn H Siegel; Beth A Drolet
Journal:  Am J Cardiol       Date:  2013-09-28       Impact factor: 2.778

7.  PHACE/S syndrome: a syndromic infantile segmental hemangioma.

Authors:  Siddram J Patil; Amol A Moray; Viralam S Kiran; Ravindra R Battu
Journal:  Indian J Pediatr       Date:  2010-10-17       Impact factor: 1.967

8.  Need for comprehensive vascular assessment before surgical repair of aortic coarctation in PHACES syndrome.

Authors:  Alessandro Giardini; Caroline Gholam; Sachin Khambadkone; Martin Kostolny
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

9.  PHACES association: a vasculocutaneous syndrome.

Authors:  Rohit P Rao; Beth A Drolet; Kristen E Holland; Peter C Frommelt
Journal:  Pediatr Cardiol       Date:  2008-04-22       Impact factor: 1.655

10.  Infantile hemangiomas β3-adrenoceptor overexpression is associated with nonresponse to propranolol.

Authors:  Andrea Bassi; Cesare Filippeschi; Teresa Oranges; Chiara Caporalini; Alessandro Pini; Patrizia Nardini; Roberta Marie Gentile; Luca Filippi
Journal:  Pediatr Res       Date:  2021-03-02       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.